BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25605416)

  • 1. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma.
    Kimura N; Toyoki Y; Ishido K; Kudo D; Yakoshi Y; Tsutsumi S; Miura T; Wakiya T; Hakamada K
    J Gastrointest Surg; 2015 May; 19(5):866-79. PubMed ID: 25605416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma.
    Kimura N; Toyoki Y; Ishido K; Kudo D; Yakoshi Y; Tsutsumi S; Miura T; Wakiya T; Hakamada K
    J Gastrointest Surg; 2015 Jun; 19(6):1194-5. PubMed ID: 25895979
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative blood transfusion and long-term outcomes after resection of hilar cholangiocarcinoma.
    Shen YN; Zhang H; Lu JH; Schwartz ME; Yang T
    J Gastrointest Surg; 2015 Jun; 19(6):1192-3. PubMed ID: 25895978
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
    Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
    Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.
    Chauhan A; House MG; Pitt HA; Nakeeb A; Howard TJ; Zyromski NJ; Schmidt CM; Ball CG; Lillemoe KD
    HPB (Oxford); 2011 Feb; 13(2):139-47. PubMed ID: 21241432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
    Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D
    Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].
    Otto G; Thies J; Hoppe-Lotichius M; Bittinger F; Pitton MB; Hadian A
    Chirurg; 2004 Jan; 75(1):59-65. PubMed ID: 14740129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study.
    Jo HS; Kim DS; Yu YD; Kang WH; Yoon KC
    World J Surg Oncol; 2020 Jan; 18(1):3. PubMed ID: 31901228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.
    Miyazaki M; Ito H; Nakagawa K; Ambiru S; Shimizu H; Okaya T; Shinmura K; Nakajima N
    J Am Coll Surg; 1999 Dec; 189(6):575-83. PubMed ID: 10589594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.
    Bhutiani N; Scoggins CR; McMasters KM; Ethun CG; Poultsides GA; Pawlik TM; Weber SM; Schmidt CR; Fields RC; Idrees K; Hatzaras I; Shen P; Maithel SK; Martin RCG
    Surgery; 2018 Apr; 163(4):726-731. PubMed ID: 29306541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video).
    De Lu C; Huang J; Wu SD; Hua YF; Javed AA; Fang JZ; Wang CN; Ye S
    J Gastrointest Surg; 2017 Nov; 21(11):1906-1914. PubMed ID: 28875398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Strategies for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma: Bile Duct Resection with or Without Hepatectomy?
    Chen RX; Li CX; Luo CH; Zhang H; Zhou T; Wu XF; Wang XH; Li XC
    Ann Surg Oncol; 2020 Sep; 27(9):3374-3382. PubMed ID: 32274664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.
    Zhang XF; Bagante F; Chen Q; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    Surgery; 2018 May; 163(5):1114-1120. PubMed ID: 29398035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.